
Conference Coverage
Latest Content

ctDNA vs. CTCs: The Future of Breast Cancer Monitoring Explained

Bridging the Gap Between Doctor and Patient in ‘Demystifying the Darkness’

Emactuzumab Demonstrates Benefit in Phase 3 TGCT Study

How Minimally Invasive Surgery Is Changing Esophageal Cancer Treatment

What Patients Should Know About Their Stage 1 Bladder Cancer

Shorts










Podcasts
Videos
All News

Meetings like SGO drive collaboration and patient-centered progress, as Dr. Ginger J. Gardner highlights their role in advancing access and research.

Persistent heartburn may signal more than GERD. Learn how reflux can lead to Barrett’s esophagus and increase esophageal cancer risk.

April is Testicular Cancer Awareness Month. Join me this month raising awareness among young men ages 15 to 35 of one the handful of cancers that impacts men before adulthood.

Rezatapopt shows activity in TP53-mutated ovarian cancer, with responses seen across heavily pretreated patient groups and manageable side effects.

Daraxonrasib improved overall survival versus chemotherapy in metastatic pancreatic cancer.

A leukemia survivor shares how her experience inspired a national support network for young adults navigating cancer and survivorship.

Dr. Kemi Doll reports that peer support helped Black women with high-risk endometrial cancer complete treatment in the SISTER trial.

Gynecologic oncology is evolving beyond surgery, with greater focus on systemic therapies, team-based care and improved patient outcomes.

Real-world data show ADCs benefit more diverse, older and pretreated patients, helping guide care and build confidence beyond limited clinical trial populations.

Treatment with Verzenio and letrozole may help control advanced or recurrent endometrial cancer for some patients, according to new research.

Learn what an invasive breast cancer diagnosis means and explore treatment options, including surgery and targeted therapy, in this patient education guide.


An expert highlights global barriers to cancer care and outlines solutions to improve access, education and equity for patients worldwide.

Dr. Sheri Prentiss shares how early detection and patient advocacy can prevent chronic lymphedema and improve quality of life for cancer survivors.
















